Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study

Authors

Institutions

Publication Details

Journal
The Lancet Microbe
Published
2025-06-11
DOI
https://doi.org/10.1016/j.lanmic.2025.101126
Citations
4
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
5.58
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study

Trang Le, Michael H. Silverman, Sigmund J. Haidacher, Eugene Poggio et al.
4 citations
The Lancet Microbe
Clostridium difficile and Clostridium perfringens research
5.58
article

Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study

Trang Le, Michael H. Silverman, Sigmund J. Haidacher, Eugene Poggio, Jacob McPherson, Taryn A Eubank, Thomas D. Horvath, Julie Mercier, Murray P. Ducharme, Kevin W. Garey, Corinne Seng Yue, Jinhee Jo, Rong Lin, M. Jahangir Alam, Khurshida Begum, Jeffrey Alder, Georges Koudssi
article en
4 citations

Abstract

No abstract available for this paper.
The Lancet MicrobeVol. 6(8)
Eloxx Pharmaceuticals (United States) (US), Altasciences (Canada) (CA), Lear (Spain) (ES), Texas Children's Hospital (US), Biostatistical Consulting (United States) (US), University of Houston (US), Lear (United States) (US)
Openalex Percentile: Top 4%
Clostridium difficile and Clostridium perfringens research
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study — Trang Le, Michael H. Silverman, et al. · The Lancet Microbe (2025) | TGRS Research Map | TGRS